Showing results (51-60 of 252) with videos related to
Sort By:
Pageof 26
Brain Research|September 20, 1991
Stimulus-evoked changes in neostriatal dopamine levels in awake and anesthetized rats as measured by microdialysisJ M Tepper, I Creese, D H SchwartzCurrent Protocols in Neuroscience|April 23, 2008
Reducing gene expression in the brain via antisense methodsA M Ouagazzal, J M Tepper, I CreeseScience (New York, N.Y.)|April 30, 1976
Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugsI Creese, D R Burt, S H SnyderMolecular Pharmacology|February 1, 1985
Interactions of dopamine agonists with brain D1 receptors labeled by 3H-antagonists. Evidence for the presence of high and low affinity agonist-binding statesS E Leff, M W Hamblin, I CreeseNeurochemistry International|March 1, 1992
Expression of rat striatal D1 and D2 dopamine receptor mRNAs: ontogenetic and pharmacological studiesI Creese, D R Sibley, S X XuThe Journal of Biological Chemistry|June 10, 1982
Anterior pituitary dopamine receptors. Demonstration of interconvertible high and low affinity states of the D-2 dopamine receptorD R Sibley, A De Lean, I CreesePsychopharmacology|December 1, 1996
Regulation of ionotropic glutamate receptors following subchronic and chronic treatment with typical and atypical antipsychoticsF I Tarazi, W J Florijn, I CreeseThe Journal of Neuroscience : the Official Journal of the Society for Neuroscience|October 1, 1995
Restricted eating with weight loss selectively decreases extracellular dopamine in the nucleus accumbens and alters dopamine response to amphetamine, morphine, and food intakeE N Pothos, I Creese, B G HoebelEuropean Journal of Pharmacology|March 1, 1976
Butyrophenone influences on the opiate receptorI Creese, A P Feinberg, S H SnyderScience (New York, N.Y.)|April 15, 1977
Antischizophrenic drugs: chronic treatment elevates dopamine receptor binding in brainD R Burt, I Creese, S H SnyderPageof 26